Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Aug-24 6:05 PM View:  | Drutz David Director | PharmAthene, Inc. (ALT) | 19-Aug-24 | Option Exercise | 41,750 | $2.55 | $106,375.00 | 140% 29.79K to 71.53K | |
| 20-Aug-24 6:05 PM View: | Drutz David Director | PharmAthene, Inc. (ALT) | 19-Aug-24 | Option Sale | 16,011 | $6.90 | $110,547.00 | (22%) 71.53K to 55.52K | |
| 01-Aug-24 5:43 PM View: | Jordt Raymond M Chief Business Officer | PharmAthene, Inc. (ALT) | 31-Jul-24 | Grant | 917 | $5.41 | $4,960.97 | 7% 13.74K to 14.66K | |
| 01-Aug-24 5:45 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 31-Jul-24 | Grant | 650 | $5.41 | $3,516.50 | 2% 42.67K to 43.33K | |
| 01-Aug-24 5:47 PM View: | Shutterly Andrew Acting Chief Financial Officer | PharmAthene, Inc. (ALT) | 31-Jul-24 | Grant | 1,259 | $5.41 | $6,811.19 | 12% 10.11K to 11.37K | |
| 01-Aug-24 5:40 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 31-Jul-24 | Grant | 1,486 | $5.41 | $8,039.26 | 3% 53.63K to 55.12K | |
| 05-Feb-24 6:02 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 02-Feb-24 | Payment of Exercise | 2,330 | $9.32 | $21,715.60 | (5%) 45.01K to 42.67K | |
| 05-Feb-24 6:02 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 02-Feb-24 | Option Exercise | 7,775 | -- | -- | 21% 37.23K to 45.01K | |
| 05-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 02-Feb-24 | Payment of Exercise | 2,332 | $9.32 | $21,734.20 | (4%) 55.97K to 53.63K | |
| 05-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 02-Feb-24 | Option Exercise | 7,775 | -- | -- | 16% 48.19K to 55.97K | |
| 05-Feb-24 6:00 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 02-Feb-24 | Payment of Exercise | 8,376 | $9.32 | $78,064.30 | (3%) 300.4K to 292.03K | |
| 05-Feb-24 6:00 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 02-Feb-24 | Option Exercise | 18,950 | -- | -- | 7% 281.45K to 300.4K | |
| 05-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 01-Feb-24 | Payment of Exercise | 1,801 | $9.88 | $17,793.90 | (4%) 49.99K to 48.19K | |
| 05-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 01-Feb-24 | Option Exercise | 6,166 | -- | -- | 14% 43.83K to 49.99K | |
| 05-Feb-24 6:00 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 01-Feb-24 | Payment of Exercise | 7,313 | $9.88 | $72,252.40 | (3%) 288.77K to 281.45K | |
| 05-Feb-24 6:00 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 01-Feb-24 | Option Exercise | 16,545 | -- | -- | 6% 272.22K to 288.77K | |
| 05-Feb-24 6:02 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 01-Feb-24 | Payment of Exercise | 1,801 | $9.88 | $17,793.90 | (5%) 39.03K to 37.23K | |
| 05-Feb-24 6:02 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 01-Feb-24 | Option Exercise | 6,166 | -- | -- | 19% 32.87K to 39.03K | |
| 01-Feb-24 6:00 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 4,621 | $2.69 | $12,430.50 | 11% 40.39K to 45.01K | |
| 01-Feb-24 6:03 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 5,860 | $2.69 | $15,763.40 | 22% 27.0K to 32.87K | |
| 01-Feb-24 6:02 PM View: | Jordt Raymond M Chief Business Officer | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 5,030 | $2.69 | $13,530.70 | 58% 8.71K to 13.74K | |
| 01-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 3,257 | $2.69 | $8,761.33 | 8% 40.57K to 43.83K | |
| 01-Feb-24 6:01 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 7,889 | $2.69 | $21,221.40 | 3% 264.33K to 272.22K | |
| 01-Feb-24 6:03 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 2,709 | $9.80 | $26,548.20 | (9%) 29.71K to 27.0K | |
| 01-Feb-24 6:00 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 9,275 | -- | -- | 28% 33.29K to 42.57K | |
| 01-Feb-24 6:03 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 9,275 | -- | -- | 45% 20.44K to 29.71K | |
| 01-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 2,709 | $9.80 | $26,548.20 | (6%) 43.28K to 40.57K | |
| 01-Feb-24 6:01 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 9,275 | -- | -- | 27% 34.0K to 43.28K | |
| 01-Feb-24 6:01 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 11,697 | $9.80 | $114,631.00 | (4%) 276.03K to 264.33K | |
| 01-Feb-24 6:01 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 26,775 | -- | -- | 11% 249.25K to 276.03K | |
| 01-Feb-24 6:00 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 2,175 | $9.80 | $21,315.00 | (5%) 42.57K to 40.39K | |
| 04-Jan-24 6:00 PM View: | Jordt Raymond M Chief Business Officer | PharmAthene, Inc. (ALT) | 01-Jan-24 | Payment of Exercise | 2,503 | $11.25 | $28,158.80 | (22%) 11.21K to 8.7K | |
| 04-Jan-24 6:00 PM View: | Jordt Raymond M Chief Business Officer | PharmAthene, Inc. (ALT) | 01-Jan-24 | Option Exercise | 9,375 | -- | -- | 512% 1.83K to 11.21K | |
| 02-Jan-24 6:00 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 29-Dec-23 | Option Exercise | 12,500 | -- | -- | 52% 23.84K to 36.34K | |
| 02-Jan-24 6:00 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 29-Dec-23 | Payment of Exercise | 3,044 | $11.25 | $34,245.00 | (8%) 36.34K to 33.29K | |
| 15-Aug-23 6:46 PM View: | Drutz David Director | PharmAthene, Inc. (ALT) | 15-Aug-23 | Private Purchase | 300 | $2.88 | $862.50 | 1% 29.48K to 29.79K | |
| 02-Aug-23 5:49 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 691 | $2.81 | $1,941.71 | 2% 33.31K to 34.0K | |
| 02-Aug-23 5:54 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 126 | $2.81 | $354.06 | < 1% 249.13K to 249.25K | |
| 02-Aug-23 5:47 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 568 | $2.81 | $1,596.08 | 3% 19.87K to 20.44K | |
| 02-Aug-23 5:51 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 1,825 | $2.81 | $5,128.25 | 8% 22.01K to 23.84K | |
| 02-Aug-23 5:43 PM View: | Jordt Raymond M Chief Business Officer | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 1,832 | $2.81 | $5,147.92 | 100% 0 to 1.83K | |
| 24-Mar-23 8:54 PM View: | Eisenstadt Richard I Chief Financial Officer | PharmAthene, Inc. (ALT) | 24-Mar-23 | Private Purchase | 10,000 | $4.31 | $43,140.00 | 83% 12.01K to 22.01K | |
| 27-Mar-23 5:17 PM View: | Drutz David Director | PharmAthene, Inc. (ALT) | 23-Mar-23 | Private Purchase | 9,000 | $4.27 | $38,430.00 | 44% 20.48K to 29.48K | |
| 23-Mar-23 8:28 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 23-Mar-23 | Private Purchase | 10,000 | $4.22 | $42,200.00 | 43% 23.31K to 33.31K | |
| 06-Feb-23 4:30 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 02-Feb-23 | Option Exercise | 18,950 | -- | -- | 8% 238.6K to 257.55K | |
| 06-Feb-23 4:31 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 02-Feb-23 | Payment of Exercise | 2,375 | $15.04 | $35,720.00 | (11%) 22.25K to 19.87K | |
| 06-Feb-23 4:30 PM View: | Garg Vipin K President and CEO Director | PharmAthene, Inc. (ALT) | 02-Feb-23 | Payment of Exercise | 8,422 | $15.04 | $126,667.00 | (3%) 257.55K to 249.13K | |
| 06-Feb-23 4:31 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 02-Feb-23 | Option Exercise | 7,775 | -- | -- | 43% 17.9K to 25.68K | |
| 06-Feb-23 4:31 PM View: | Roberts M Scot Chief Scientific Officer | PharmAthene, Inc. (ALT) | 02-Feb-23 | Option Exercise | 7,775 | -- | -- | 54% 14.47K to 22.25K | |
| 06-Feb-23 4:31 PM View: | Harris Matthew Scott Chief Medical Officer | PharmAthene, Inc. (ALT) | 02-Feb-23 | Payment of Exercise | 2,364 | $15.04 | $35,554.60 | (9%) 25.68K to 23.31K |
